跳转至内容
Merck
CN
  • Thiazide-induced severe hypercalcemia: a case report and review of literature.

Thiazide-induced severe hypercalcemia: a case report and review of literature.

American journal of therapeutics (2010-01-14)
Harit V Desai, Kaushang Gandhi, Mala Sharma, Michaud Jennine, Parminder Singh, Maureen Brogan
摘要

Most common causes of hypercalcemia are hyperparathyroidism, malignancy, vitamin D-mediated conditions such as sarcoidosis, and vitamin D toxicity. Less commonly, hypercalcemia can be caused by drugs such as thiazide diuretics and lithium. Mild hypercalcemia is usually asymptomatic but severe hypercalcemia is associated with nausea, vomiting, abdominal pain, excessive thirst, muscle weakness, lethargy, confusion, and fatigue. We are reporting a case of abdominal pain and altered mental status caused by thiazide-induced severe hypercalcemia of 19.8 mg/dL. This is the most severe case of thiazide-induced hypercalcemia that we have seen reported. Patients on thiazide diuretics should have their electrolytes frequently checked, especially patients on calcium supplements. Management usually includes hydration and discontinuation of drugs causing hypercalcemia.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
柠檬酸钙四水合物, 99%